Response Biomedical Corporation (Response) develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical and environmental applications. RAMP represents a paradigm in diagnostics that provides sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The RAMP system is a platform technology that combines a sensitive, portable fluorescence detection system with simple lateral flow immunoassays. RAMP maintains key positive attributes of lateral flow immunoassays - simplicity, specificity, reliability and rapid results - but includes a method to overcome the performance limitations of early generation immunoassays that suffer from relatively poor sensitivity and precision.